Neovacs S.A announced that it has entered into financing contract to issue 5,000 convertible bonds, warrants or exchangeable into new and or existing shares with a par value of €10,000 each for gross proceeds of €50,000,000 over a maximum period of 48 months on September 5, 2021. The transaction will include participation from Luxembourg fund an High Growth Opportunities Securitization Fund, member of the Alpha Blue Ocean group. The company will receive broken down into fifty tranches of 100 OCEAEs each, accompanied by share subscription warrants.